APA aipamena

Krust, B., Vienet, R., Cardona, A., Rougeot, C., Jacotot, E., Callebaut, C., . . . Edelman, L. (2001). The anti-HIV pentameric pseudopeptide HB-19 is preferentially taken up in vivo by lymphoid organs where it forms a complex with nucleolin. The National Academy of Sciences.

Chicago Style aipamena

Krust, B., et al. The Anti-HIV Pentameric Pseudopeptide HB-19 Is Preferentially Taken Up in Vivo By Lymphoid Organs Where It Forms a Complex With Nucleolin. The National Academy of Sciences, 2001.

MLA aipamena

Krust, B., et al. The Anti-HIV Pentameric Pseudopeptide HB-19 Is Preferentially Taken Up in Vivo By Lymphoid Organs Where It Forms a Complex With Nucleolin. The National Academy of Sciences, 2001.